No. hystrix aims to improve the profitability for not only buyers, but also for medical product and service sellers as well. By removing inefficiency and waste, sellers can retain and even increase profitability in spite of their sometimes lowering their selling prices. Lower selling prices tend to be a concession sellers are willing to entertain as a result of their being able to lock in longer dated contracts and avoid ad-hoc buying from buyers that now actively use the hystrix platform. Buyers on hystrix must take delivery (unless specifically agreed with a supplier otherwise) of all those items that they contract to purchase over hystrix. Hence, whilst there is a risk that prices may be negatively impacted by the move to a digital channel, smart suppliers have realised that the trade-offs made result in most instances in higher profit margins overall.

Prices are only visible to buyers but not to other suppliers. hystrix allows suppliers to add their discount structures to the marketplace. Prices visible to purchasers depend (for the most part) on the volume (number of units) to be contracted, thus eliminating the need for lengthy quantity discount negotiations. In addition, hystrix has integrated digital negotiation-specific processes and chat functionality that drastically reduces the time required to conclude a contract.

No. MedTech devices, medical products and instruments, as well as all consumables and furniture procured by health institutions are available on hystrix. Services related to those products can also be contracted over the marketplace.

All contracts concluded via hystrix are based on the hystrix General Terms & Conditions (“GTC”), which define the rights and obligations of the contracting parties. The contracting parties (the procuring and the supplying institution) accept the GTC anew each time a contract is concluded and essentially undertake to purchase or supply certain quantities (number of units) of an item at a certain price (CHF excl. VAT, including delivery) during a certain contract period.

No. Mediclinic will not be granted access to any competitor or proprietary data other than what is and will be available to other procuring users.

No. Mediclinic will not be granted access to any competitor or proprietary data other than what is and will be available to other procuring users.

No. hystrix uses all market information exclusively to adapt its own developments to the needs of the market. Concrete requirements can be discussed anonymously on a quantitative basis.